版權(quán)說明:本文檔由用戶提供并上傳,收益歸屬內(nèi)容提供方,若內(nèi)容存在侵權(quán),請(qǐng)進(jìn)行舉報(bào)或認(rèn)領(lǐng)
文檔簡(jiǎn)介
/哈爾濱醫(yī)科大學(xué)八十周年校慶系列學(xué)術(shù)活動(dòng)——如何進(jìn)行科學(xué)實(shí)驗(yàn)研究的基礎(chǔ)訓(xùn)練課5月30日9:30-11:30AM如何進(jìn)行科學(xué)研究(概述)和如何復(fù)習(xí)文獻(xiàn)(唐朝樞教授)2:00-4:00PM代謝綜合征(核轉(zhuǎn)錄因子及實(shí)驗(yàn)?zāi)P蛻?yīng)用)(管又飛教授)4:00—6:00PM轉(zhuǎn)錄因子調(diào)控相關(guān)實(shí)驗(yàn)研究(朱毅教授)7:30-9:30PM組織特異基因敲除技術(shù)及其應(yīng)用(管又飛教授)5月31日8:00-10:00AM如何設(shè)計(jì)研究課題(唐朝樞教授)10:00—12:00AM蛋白質(zhì)組學(xué)技術(shù)及應(yīng)用(王憲教授)2:00-4:00PM如何撰寫實(shí)驗(yàn)研究論文(唐朝樞教授)4:00-6:00PM如何撰寫和發(fā)表英文論文(王憲教授)7:30—9:30PM如何作科學(xué)學(xué)術(shù)報(bào)告(朱毅教授)6月1日8:00-12:00AMWesternblot技術(shù)詳解:?jiǎn)栴}與對(duì)策(徐國(guó)恒教授)2:00-4:00PM病毒載體技術(shù)及疾病的基因治療(汪南平教授)4:00-6:00PMRNA沉默及microRNA技術(shù)(汪南平教授)地點(diǎn):主樓后樓科技會(huì)館北京大學(xué)醫(yī)學(xué)部生理和病理生理系(負(fù)責(zé)教師:系主任王憲教授)教育部和衛(wèi)生部心血管分子生物學(xué)重點(diǎn)實(shí)驗(yàn)室教育部創(chuàng)新團(tuán)隊(duì)唐朝樞教授簡(jiǎn)介唐朝樞,男,教授,博士生導(dǎo)師。1968北京醫(yī)學(xué)院醫(yī)學(xué)系畢業(yè),1981獲北京醫(yī)學(xué)院病理生理學(xué)專業(yè)碩士學(xué)位.1990年晉升為教授。1993年評(píng)為博士生導(dǎo)師。曾四次赴美國(guó)進(jìn)修和合作研究.曾任國(guó)家九七三項(xiàng)目(心腦血管疾病發(fā)病和防治基礎(chǔ)研究)首席科學(xué)家,長(zhǎng)期從事心血管生理及病理機(jī)制方面的科研和教學(xué)工作。兼任《生理學(xué)報(bào)》、《生理科學(xué)進(jìn)展》、《北京大學(xué)學(xué)報(bào)(醫(yī)學(xué)版)》,《中國(guó)動(dòng)脈硬化雜志》,《中華老年多器官功能障礙雜志》和《國(guó)際病理科學(xué)和臨床雜志》副主編,《中華醫(yī)學(xué)雜志》、《中華心血管病雜志》和《中國(guó)醫(yī)學(xué)科學(xué)院學(xué)報(bào)》等雜志編委。參編、主編《病理生理學(xué)》教科書及《休克學(xué)》、《老年心臟病學(xué)》和《動(dòng)脈粥樣硬化性心血管病.基礎(chǔ)與臨床》等專著多部。至今已發(fā)表SCI收錄論文壹百余篇。曾獲國(guó)家科技進(jìn)步二等獎(jiǎng)(1998年),部委一等獎(jiǎng)(1991、1997、2003和2005年)、二、三等獎(jiǎng)等多項(xiàng)獎(jiǎng)項(xiàng)。82802183.E—mail:tangchaosh.cn王憲教授,博士生導(dǎo)師。1980。1北京醫(yī)學(xué)院醫(yī)療系畢業(yè),1985年獲病理生理學(xué)碩士學(xué)位,1992年獲生理學(xué)博士學(xué)位.曾在美國(guó)芝加哥勞約拉大學(xué)醫(yī)學(xué)院生理系和免疫系以及美國(guó)肯塔基州立大學(xué)醫(yī)學(xué)院生理系進(jìn)修4年多。曾獲首屆國(guó)家杰出青年科學(xué)基金,第二屆全國(guó)中青年醫(yī)學(xué)科技之星;中國(guó)青年科學(xué)家獎(jiǎng);香港求是科技基金會(huì)設(shè)立的"杰出青年學(xué)者獎(jiǎng)”;2000年被聘為教育部長(zhǎng)江特聘教授.現(xiàn)任北京大學(xué)基礎(chǔ)醫(yī)學(xué)院生理學(xué)與病理生理學(xué)系主任.兼任中國(guó)生理學(xué)會(huì)常務(wù)理事,【生理科學(xué)進(jìn)展】常務(wù)編委等。十幾年以來,共獨(dú)立主持包括美國(guó)洛克菲勒生物技術(shù)專業(yè)基金、國(guó)家杰出青年科學(xué)基金、美國(guó)中華醫(yī)學(xué)血管生物學(xué)基金子項(xiàng)目、心血管國(guó)家重點(diǎn)基礎(chǔ)研究發(fā)展規(guī)劃"973”子項(xiàng)目和國(guó)家自然科學(xué)基金重點(diǎn)項(xiàng)目等十幾項(xiàng)科研課題的研究工作。她的實(shí)驗(yàn)室主要從事神經(jīng)-免疫調(diào)節(jié)機(jī)制及其在心血管疾病發(fā)病中意義的研究工作,特別是關(guān)于動(dòng)脈粥樣硬化發(fā)病時(shí)血管炎癥免疫的發(fā)病機(jī)制和抗炎癥保護(hù)機(jī)制.該室研究特點(diǎn)是采取跨學(xué)科研究,將免疫學(xué)與心血管疾病發(fā)病機(jī)制研究緊密結(jié)合,將基礎(chǔ)醫(yī)學(xué)與臨床醫(yī)學(xué)的研究緊密結(jié)合。此外,近年來還采用蛋白質(zhì)組學(xué)技術(shù),尋找參與心血管缺氧/預(yù)適應(yīng)和動(dòng)脈粥樣硬化發(fā)病的新的內(nèi)源性介導(dǎo)物質(zhì)。王憲已發(fā)表原著論文120余篇,其中在國(guó)際SCI雜志上發(fā)表的文章60余篇。代表性5篇研究論文如下:?1.Wang,W。,L。Jia,T.Wang,W。Sun,S。Wu,X。Wang*。Endogenouscalcitoninegene-relatedpeptideprotectshumanalveolarcellsthroughproteinkinaseCandheatshockprotein。JBiolChem,2005,280:20325-20330.徐國(guó)恒教授簡(jiǎn)介徐國(guó)恒,男,1964年生,醫(yī)學(xué)博士;北京大學(xué)醫(yī)學(xué)部生理學(xué)系教授,博士研究生導(dǎo)師;教育部分子心血管重點(diǎn)實(shí)驗(yàn)室PrincipleInvestigator.1987年河南醫(yī)科大學(xué)臨床醫(yī)療系本科畢業(yè)獲學(xué)士學(xué)位;1990年于河南醫(yī)科大學(xué)藥理學(xué)系獲醫(yī)學(xué)碩士學(xué)位,1995年于中山醫(yī)科大學(xué)藥理系獲醫(yī)學(xué)博士學(xué)位。1995-1997年北京醫(yī)科大學(xué)神經(jīng)科學(xué)中心做博士后.1997年底赴美國(guó)國(guó)立衛(wèi)生研究院(NIH)兒童健康與人類發(fā)育研究所(NICHD)內(nèi)分泌生理實(shí)驗(yàn)室做博士后研究員,研究促腎上腺皮質(zhì)激素釋放激素受體基因調(diào)控。1999年底轉(zhuǎn)入美國(guó)NIH糖尿病消化和腎病研究所(NIDDK)細(xì)胞發(fā)育生物學(xué)實(shí)驗(yàn)室做博士后研究員,研究細(xì)胞內(nèi)脂滴(LipidDroplet)及脂滴包被蛋白的細(xì)胞生物學(xué),以及脂肪分解代謝、肥胖、糖尿病胰島素抵抗的分子機(jī)制.2002年底回國(guó)于北京大學(xué)醫(yī)學(xué)部生理系工作。目前承擔(dān)2項(xiàng)國(guó)家自然科學(xué)基金面上項(xiàng)目,1項(xiàng)北京市自然科學(xué)基金面上項(xiàng)目,1項(xiàng)新世紀(jì)優(yōu)秀人才支持計(jì)劃基金.2004年入選教育部新世紀(jì)優(yōu)秀人才支持計(jì)劃。任《生物學(xué)通報(bào)》常務(wù)編委、《中華糖尿病雜志》特約編委。研究方向:1.脂肪分解和脂肪酸運(yùn)動(dòng)的分子調(diào)控機(jī)制2.肥胖、胰島素抵抗、泡沫細(xì)胞形成的細(xì)胞生物學(xué)機(jī)制近5年來發(fā)表論文:TingtingRen,JinhanHe,HongfengJiang,LuxiaZu,ShenshenPu,XiaohuiGuo*,andGuohengXu*.Metforminblockslipolysisinprimaryratadipocytesstimulat(yī)edbytumornecrosisfactor-aorisoproterenol.JournalofMolecularEndocrinology.revised.*Correspondingauthor。劉梅芳,徐國(guó)恒*。PAT家族蛋白在細(xì)胞內(nèi)脂滴代謝過程中的作用.生理科學(xué)進(jìn)展2006,37(2):103-107*責(zé)任作者。徐沖,何金汗,徐國(guó)恒*。脂滴包被蛋白(perilipin)調(diào)控脂肪分解。生理科學(xué)進(jìn)展2006,37(3):inpress.*責(zé)任作者。JinhanHe,HongfengJiang,JohnT。Tansey,ChaoshuTang,ShenshenPu,andGuohengXu*.CalyculinandOkadaicAcidPromotePerilipinPhosphorylationandIncreaseLipolysisinPrimaryRatAdipocytes。BiochimicaetBiophysicaActa-MolCellBiolofLipid.2006;1761(2):247-255。*責(zé)任作者。XuG*,SztalrydC,KimmelAR,andLondosC.Degradationofperilipinismediatedthroughubiquitination-proteasomepathway.HYPERLINK”"\l”description”BiochimicaetBiophysicaActa-MolCellBiolofLipid.2006;1761(1):83-90.*責(zé)任作者。XuG,SztalrydC,LuX,DorwardH,TanseyJT,KimmelAR,andLondosC.Post-translationalregulationofadiposedifferentiation-relatedproteinbytheubiquitin/proteasomepathway。JournalofBiologicalChemistry.2005Dec;280(52):42841—7。ZhangM,WangX,ZhangD,XuG,DongH,YuY,HanJ.OrphaninFQantagonizestheinhibitionofCa(2+)currentsinducedbymicro-opioidreceptors。JournalofMolecularNeuroscience。2005;25(1):21—7.SztalrydC,XuG,DorwardH,TanseyJT,ContrerasJA,KimmelAR,andLondosC.PerilipinisEssentialfortheTranslocationofHomone-sensitiveLipaseduringLipolyticActivation.JournalofCellBiology.2003Jun23;161(6):1093-1103。徐國(guó)恒XuG與SztalrydC為共同第一作者.XuG,Rabadan—DiehlC,NikodemovaM,WynnP,SpiessJ,AguileraG.Inhibitionofcorticotropinreleasinghormonetype-1receptortranslationbyanupstreamAUGtripletinthe5’untranslatedregion.MolecularPharmacology。2001;59(3):485-492。朱毅教授簡(jiǎn)介朱毅,教授.1983年本科畢業(yè)于西安醫(yī)科大學(xué),1986年獲醫(yī)學(xué)碩士學(xué)位.1993年在瑞士洛桑大學(xué)醫(yī)學(xué)院獲醫(yī)學(xué)博士學(xué)位。1993-1997年先后在美國(guó)紐約醫(yī)學(xué)院及美國(guó)加州大學(xué)Riverside校區(qū)(UCR)做博士后訓(xùn)練。1998年1月至2003年9月于UCR生物醫(yī)學(xué)系任研究助理教授。2003年10月起在北京大學(xué)醫(yī)學(xué)部生理學(xué)與病理生理學(xué)系任教授。多年來,一直從事血管內(nèi)皮激活的信號(hào)傳導(dǎo),脂蛋白和血管內(nèi)皮的相互作用及動(dòng)脈粥樣硬化形成的分子機(jī)制等方面研究,共在SCI核心期刊發(fā)表論文三十余篇。他領(lǐng)導(dǎo)的脂代謝與動(dòng)脈粥樣硬化研究室的總體研究方向?yàn)橐匝軆?nèi)皮激活及動(dòng)脈粥樣硬化形成機(jī)制為主的血管生物學(xué)。正在進(jìn)行的課題方向包括:脂蛋白LDL和HDL與血管內(nèi)皮的相互作用以及內(nèi)皮在血管壁脂質(zhì)平衡中所起的作用和分子機(jī)制。血流動(dòng)力學(xué)在局灶性動(dòng)脈粥樣硬化形成中的作用機(jī)制。內(nèi)皮細(xì)胞膜亞結(jié)構(gòu)caveolae在血管壁脂質(zhì)轉(zhuǎn)運(yùn)中的作用機(jī)制及與代謝綜合征血管病變的關(guān)系;不同的代謝性核受體和轉(zhuǎn)錄因子之間的相互作用以及代謝綜合征、糖尿病發(fā)病機(jī)制研究。5篇代表論文(*責(zé)任作者):ZhuY,*LiaoHL,WangN,YuanY,MaK-S,VernaL,StemermanMB。(2000)Lipoproteinpromotescaveolin—1andRastranslocationtocaveolae:roleofcholesterolinendothelialsignaling。ArterioThrombVascBiol20:2465-2470。ZhuY,*LiaoHL,WangN,MaK—S,VernaL,ShyyJY-J,ChienS,StemermanMB.(2001)Low—densitylipoprotein—activatedp38inendothelialcellsismediatedbyRas.ArterioThrombVascBiol21:1159-1164.LiaoHL,LangmannT,SchmitzG,ZhuY.*(2002)NativeLDLtranscriptionalyupregulatesATP-bindingcassettetransporter-1inhumanvascularendothelialcells。ArterioThrombVascBiol22:127-132。ZhuY,*LiaoHL,YuanY,VernaL,StemermanMB.(2003)LowdensitylipoproteininduceseNOStranslocat(yī)iontomembranecaveolaeviastressfibers。BiochemBiophysActa1635:117—126ZhuY,*LiaoH,XieXF,YuanY,LeeT-S,WangN,WangX,ShyyJY—J,StemermanMB。(2005)OxidizedLDLdownregulat(yī)esATP—bindingcassettetransporter—1inhumanvascularendothelialcellsviainhibitingLXR。CardiovasRes68:425-432.(witheditorial68:353-354)管又飛教授YOUFEIGUAN,M.D。,Ph。D.Birthdateandplace:Feb。,15,1965Maritalstatus:married,twosons.EDUCATION:M.D.inMedicine,July,1986DepartmentofInternalMedicine,NantongMedicalCollege,Nantong,JiangsuProvince226001,CHINAM.S.inNephrology,Oct。,1989DepartmentofInternalMedicine,NantongMedicalCollege,Nantong,JiangsuProvince226001,CHINAPh.DinNephrology,Nov.,1993InstituteofNephrology,BeijingMedicalUniversity,Beijing100034,CHINAPostdoctoralResearchFellow,1994—1999DivisionofNephrology,DepartmentofMedicine,VanderbiltUniversityMedicalCenter,Nashville,TN37232APPOINTMENTS:2005,04-presentChangjiangProfessorofPathophysiologyTheMinistryofEducat(yī)ion,People’sRepublicofChina2003,09-presentDirector,PekingUniversityDiabetesCenter2002,09-presentProfessorofPhysiologyDepartmentofPhysiologyandPathophysiology,Peking(Beijing)UniversityHealthScienceCenter,Beijing100083;1999,09-2002,09AssistantProfessorofMedicineDivisionofNephrology,DepartmentofMedicine,VanderbiltUniversityMedicalCenter,Nashville,TN372321989,08—1991,07LecturerandResidentPhysicianDivisionofNephrology,DepartmentofInternalMedicine,TheAffiliatedHospitalofNantongMedicalCollege,Nantong,JiangsuProvince226001,CHINA1986,09—1989,08GraduateResearch,TeachingAssistantandResidentPhysicianDepartmentofInternalMedicine,NantongMedicalCollege,Nantong,JiangsuProvince226001,CHINAMEMBERSHIPOFACADEMICASSOCIATION:MemberofAmericanSocietyofNephrology(ASN);MemberofInternationalSocietyofNephrology(ISN);MemberofAmericanPhysiologicalSociety(APS)MemberofChineseSocietyofPhysiology(CSP)MemberofAmericanDiabetesAssociation(ADA)MemberofAmericanAssociationfortheAdvancementofScience(AAAS)AWARDANDHONORPOSITION:NationalGuangHuaPrice,1993,BeijingMedicalUniversityGuestAssociat(yī)eProfessor,1998,05-2001,05,DepartmentofPhysiology,BeijingUniversityMedicalCenter(BeijingMedicalUniversity),Beijing100081;GuestProfessor,2002,1-present,DivisionofNephrology,TheGeneralHospitalofPLA,Beijing100021ACADEMICPOSITION:Co-Chair,theSymposium“NovelRenalPathwaysforPreventionofDiabetesandObesity-Relat(yī)edRenalandVascularDisease”.The2005A(chǔ)nnualMeetingoftheASN,Nov8-13,Philadelphia,Pennsylvania.Chairman,theEicosanoidReceptorsSymposium,theInternationalEicosanoidsConference,Beijing,July05,2005Reviewer,StudySectionofPhysiology,PathophysiologyandInternalMedicine,NationalNatureScienceFoundationofChina(NNSFC),2004-2008Reviewer,StudySectionofImmunology,NationalNatureScienceFoundationofChina(NNSFC),2005;ReviewCommitteemember,NIDDKRFA—DK-04-012,StudySectionof“PKDResearchandTranslationCoreCenters”;ReviewCommitteemember,NIDDKRFA—DK—05—001,StudySectionof“PreventingMitochondrialOxidat(yī)iveStressinDiabetesandObesity”;Chairman,TheCross-SectionSymposium“"PPARsinphysiologyandpathophysiology",2003FASEBmeeting,April11-14,SanDiego.Chair,ThefirstDiabetesSymposiumat(yī)BeijingUniversityMedicalCenter,December20,2003;INVITEDREVIEWS:BreyerMD,ZhangY,GuanY,HaoCM,HebertRL,BreyerRM。RegulationofrenalfunctionbyprostaglandinEreceptors。KidneyInt。1998;54(suppl。67):S88—S94GuanYandBreyerMD.Perliferator—activatedreceptors(PPARs):Noveltherapeutictargetsinrenaldisease.KidneyInt.2001;60(1):14—30.GuanY,ZhangYandBreyerMD:TheroleofPPARsinthetranscriptionalcontrolofcellularprocesses.DrugNews&Perspective2002;15(3):147—154.GuanY:Peroxisomeproliferator-activatedreceptors(PPARs):Noveltherapeutictargetsforpreventionofdiabetes,dyslipidemia,hypertensionandobesity。MinervaUrologicaeNefrologica2002;54:65—79GuanY:PPARsystemanditsrelationshiptorenalcomplicationsofthemetabolicsyndrome。J。Am.Soc。Nephrol。(invitedreview)2004Nov;15(11):2801-15.GuanY:PPAR—gammaagonistsanddiabeticnephropathy.CurrentDiabetesReports(inpresss)(InvitedReview)。BOOKCHAPTERSTargetedgenedisruptionofstaglandinE2EP2receptor。InEicosanoidsandOtherBioactiveLipidsinCancer,Inflammation,andRadiationI(lǐng)njury.EditedbyHonnetal.,pp321—326,KluwerAcademic/PlenumPublishers,2002Vasoactivesubstancesandkidney。inNephrology。EditedbyHaiyanWang。2nded.pp84-180,PublicHealthPublishHouse.Beijing.China.1996EndocrinologicalFunctionofKidney.InModernNephrology.EditedbyJijeJiang.1sted。MilitaryMedicinePublishHouse(inpress)Peroxisomeproliferator—activatedreceptors(PPARs)andcardiovasculardisease.InPracticalCardiovascularReceptorology.EditedbyDaowenWang.1sted.SciencePress,Beijing,ISBN7—03—009284-8/R。687,2001,P50-61ScavengerReceptorsandcardiovasculardisease.InPracticalCardiovascularReceptorology。EditedbyDaowenWang。1sted.SciencePress,Beijing,ISBN7—03-009284-8/R。687,2001,p62—70LISTOFPUBLICATIONSYiangBandGuanY:Chronicrenalfailureandrecombinanthumanerythropoietin。ChineseJournalofNephrology.1990。6:388—391.GuanYandQianT:Fibronectinandrenaldiseases。AdvancesinInternalMedicine。1991.18(5):221-224.GuanYandXiuK:Roleofreactiveoxygenspeciesingastrointestinalischemicinjury.JiangsuMedicalJournal1991.17(6):322-324.GuanY,QianT,andJiangJ:Alterationoftheplasmafibronectinconcentrationinvariouskidneydisease.ChineseJournalofNephrology.1991。7:81—84。GuanY,ZhaoX,andJiangJ:Significanceofhypercoagulableindexesinlupusnephritis。TianjinMedicalJournal.1991。19(6):349-351.GuanY,JiangJ,andQianT:EffectoforalsupplyofessentialaminoacidsonthefunctionofkidneyandFcreceptoroftheperitonealmacrophagesinratswithchronicrenalfailure。JiangsuMedicalJournal.1991。17(1):10-12。Zhang,Y,GuanY,andJiangJ:Structuralandfunctionalchangesinagedkidneys.JiangsuMedicalJournal。1992.18(1):32-33.GuanYandJiangJ:Clinicalapplicationofrecombinanthumanerythropoietin(rhuEPO).J。Nephrol.Dialy。Transplant.1993。2(1):3-6.GuanY,JiangJ,SenY:Polypeptidegrowthfactors。AdvancesinNephrologyandUrology.1993.13(3):99-103.GuanY,WangH:Applicationofpolymerasechainreaction(PCR)techniqueinnephrology。AdvancesinNephrologyandUrology.1993.13(4):162-1655.GuanY,JiangJ,QianT:Cyclosporine-associatedhypertension.AdvancesinInternalMedicine.1993.20(2):71—73.GuanY.Decreasedexpressionofc-fosandc-junoncogenesinagedratkidneys.Oralpresentat(yī)ionattheFirstChineseNat(yī)ionalCongressofhypertension,fluid,electrolytemetabolism.Apr.19-21,1993.Shanghai。China.GuanY,XioDandJiangJ:Effectofshort—termnon-insulintherapyonserumlipidlevelsinNIDDMpatients.ActaAcademiaMedicinaeNantong.1993.12(4):337—339.GuanY,ZhangY,DavisL,BreyerMD:Differentialdistributionofperoxiliferator-activatedreceptors(PPARs)alongtheurinarytractofrabbitandman.Am。J.Physiol.(RenalPhysiol。)1997;273:F1013—F1022.GuanY,ZhangM,ChoW,ZhangY,DavisL,BreyerR,Chang,S,DuBois,RN,HaoC,BreyerMD:Cloning,expression,andregulationofrabbitcyclooxygenase-2inrenalmedullaryinterstitialcells。Am.J。Physiol.(RenalPhysiol.)1997;273:F18—F26BreyerMD,ZhangY,GuanY,HaoCM,HebertRL,BreyerRM。Regulat(yī)ionofrenalfunctionbyprostaglandinEreceptors.KidneyInt。1998;54(suppl。67):S88-S94GuanY,ZhangY,BreyerR,Fowler,B,DavisL,Hebert,RL,BreyerMD:PGE2inhibitsrenalcollectingductNa+absorptionbyactivat(yī)ingtheEP1receptor.J。Clin。Invest.1998;102:194—201Hao,C。-M.,Komh?ffM,GuanY,RedhaR,BreyerMD:Selectivetargetingofcyclooxygenase-2revealsitsroleinrenalmedullaryinterstitialcellsurvival.Am.J。Physiol.1999;277:F352—F359Kennedy,CRJ,ZhangY,BrandonS,GuanY,CoffeeK,FunkCD,MagnusonMA,OatesJA,BreyerMD,BreyerRM:HypertensionandreducedfertilityinmicelackingtheprostaglandinEP2receptor。NatureMed.1999;5:217—220GuanY,ZhangY,DavisL,RedhaR,BreyerMD:Expressionofperoxisomeproliferator-activatedreceptorinhumantransitionalbladdercanceranditsroleininducingcelldeath.Neoplasia1999;1(4):330-339.ZhangY,GuanY,SchneiderA,BrandonS,BreyerRM,BreyerMD:CharacterizationofmurinevasopressorandvasodepressorprostaglandinE2receptors。Hypertension2000,35;1129-1134K?mhoffM,GuanY,BreyerMD:Enhancedexpressionofcyclooxygenase-2inhighgradehumantransitionalcellbladdercarcinomas.Am。J.Pathol.2000,157:29-35。GuanYandBreyerMD。Peroxisomeproliferator—activatedreceptors(PPARs):Noveltherapeutictargetsinrenaldisease.KidneyInt。2001;60(1):14-30.ShappellSB,ManningS,BoeglinWE,GuanY,WheelerTM,DavisL,JackG,BreyerMD,BrashAR:Alterationsinlipoxygenaseandcyclooxygenase-2catalyticactivityandmRNAexpressioninprostatecarcinoma.Neoplasia2001;3(4):287-303.GuanY,ZhangY,BreyerMD:Peroxisomeproliferator-activatedreceptorgamma(PPAR)activityisassociatedwithrenalmicrovasculature.Am.J.Physiol.2001;281:F1036-F1046.GuanY,ZhangY,SchneiderA,DavisL,BreyerMD:cDNAcloning,genemapping,andintrarenallocalizationofmouseprostaglandinEsynthase。Am.J。Physiol.2001;281:F1173—F1177.ZhengF,F(xiàn)ornoniA,ElliotSJ,GuanY,BreyerMD,StrikerLJ,StrikerGE.PPARactivationsuppressesTGF-mediat(yī)edTypeIcollagenexpressioninmesangialcells.Am。J。Physiol。(RenalPhysiol。)2002;282:F639-648GuanYandBreyerMD:Replyfromtheauthors“Fibrat(yī)es—inducedrenalinjury”。KidneyInt。2002;61(1):354—355.JonesJR,SheltonKD,GuanY,BreyerMD,MagnusonMA.Generat(yī)ionandfunctionalconfirmationofaconditionalnullPPARalleleinmice.Genesis2002;32:134—137.GuanY,ZhangYandBreyerMD:TheroleofPPARsinthetranscriptionalcontrolofcellularprocesses。DrugNews&Perspective2002;15(3):147—154,ReviewPanzerU.,ScneiderA,GuanY,ReinkingR,ZahnerG,HarendzaS,WolfG,ThaissF,StahlRAK:Activat(yī)ionoftheperoxisomeproliferator—activatedreceptor(PPAR)increasesMCP—1expressionandmonocyteinfiltrationinexperimentalglomerulonephritis。KidneyInt.2002Aug;62(2):455-64GuanY,StillmanB,BreyerR,ZhangY,DavisL,RedhaR,NianC,BreyerMD:CloningandfunctionalexpressionoftherabbitprostaglandinEP2receptor。BMCPharmacology2002,2:14(27
June
2002)SchneiderA,ZhangY,GuanY,DavisL,BreyerRM,BreyerMD:Differential,induciblegenetargetinginrenalepithelia,vascularendothelium,andvisceraofMx1Cremice.Am.J.Physiol.(RenalPhysiol。)2003;284:F411—F417.SaitoS,GuanY,DavisL,BreyerM:ExpressionoftheprostaglandinFreceptor(FP)genealongthemousegenitourinarytract.Am.J.Physiol.(RenalPhysiol.)2003;284:F1164-1170.Peti-PeterdiJ,KomlosiP,BebokZ,GuanY,SchneiderA,QiZ,RedhaR,BreyerM,BellPD。LuminalNaCldeliveryregulatesbasolat(yī)eralPGE2releasefromintactMaculadensacells.J.Clin.Invest。2003Jul;112(1):76-82ZhangY,SchneiderA,ReenaRao,WendellJLu,F(xiàn)anXF,DavisL,BreyerR,BeryerMDandGuanY:GenomicstructureandgenitourinaryexpressionofmousecytosolicprosaglandinE2synthase(cPGES)gene.BiochimicaetBiophysicaActa-Mol.Biol.Lipid2003:1634;15—23.HebertRL,GuanY,FowlerB,BreyerMD:PGE2inhibitsrenalcollectingductsodiumtransportandthereleaseofcellcalciumbyactivatingtheEP1receptorsubtype.RecentRes。Devel.Physiol.2003;1:307—317.SchneiderA,ZhangY,ZhangM,LuW,RaoR,FanX,RedhaR,DavisL,BreyerRM,HarrisR,BreyerMD,GuanY:Membrane-associatedPGES—1(mPGES-1)isco—expressedwithbothCOX—1andCOX—2inthekidney.KidneyInt.2004;65:1205—1213。MaL,MaS-L,KanjanabuchT,GuanY,ZhangY,BrownNJ,SwiftL.L。,McguinnessO。P,WassermanD.H.,FogoA.B.PreventionofobesityandinsulinresistanceinmicelackingPAI—Igene.Diabetes2004;53:336—346。SchneiderA,GuanY,ZhangY,MagnusonMA,LoftinCD,LangenbachR,BreyerRM,andBreyerMD:GenerationofmicesuitableforconditionalprostaglandinEP4receptordeletion.Genesis2004;40:7—14GuanY.InvitedReview:PPARfamilyandrenalcomplicationsofthemetabolicsyndrome.J。Am.Soc.Nephrol。2004Nov;15(11):2801—15ZhengF,ChenQ,Plat(yī)iA-R,YeS-Q,BerhoM,BanerjeeA,PotierM,JaimesEA,GuanY,HaoC,StrikerLJ,StrikerGE.Theglomerulosclerosisofaging:Contributionoftheproinflammatorymesangialcellphenotypetomacrophageinfiltrat(yī)ion.Am.J.Pat(yī)hol。2004;165:1789-1798;WuJ,ZhangY,YangG,WangN,ZhuY,WangX,DavisL,BreyerMD,GuanY:LiverXreceptoralphamediatescholesteroleffluxinculturedmesangialcells。。Am.J。Physiol.(RenalPhysiol。)2004;287:F886-F895;XiongZ,HuangH,LIJ,GuanY,WangH:Anti-inflammatoryeffectofPPARginculturedhumanmesangialcells.RenalFailure2004;26:497-505;ZengX-K,GuanY,RemickD。G.WangX.Signalpat(yī)hwaysunderlyinghomocysteine—inducedproductionofMCP-1andIL—8inculturedhumanwholeblood.ActaPhamacologicaSinica2005;26(1):85-91;WangG,WeiJ,GuanY,JinN,MaoJ,WangX:PPARagonistrosiglitazonereducesinflammatoryresponseintypeIIdiabeticpatientswithcoronaryarterialdiseaseflowingcoronaryangioplasty.Metabolism2005;54(5):590—597.YangF,ZhangZ,XinD,ShiC,Wu(yù)JP,GuoYL,GuanY:PPARligandsinducecellcyclearrestandapoptosisinhumanrenalcarcinomacellLines。ActaPharmacologicaSinica2005;26(6):736—761.GuanY,HaoC,RaoR,ChaDR,KohanD,MagnusonM,ZhangY,BreyerMD:PPARregulatessystemicfluidvolumebyactivatingsodiumabsorptioninthecollectingduct。_NatureMedicine2005Aug;11(8):861-866;HebertR,SaitoO,CarmosinoM,YangG,JacksonC,QiZ,ZhangY,GuanY,BreyerM:CharacterizationoftherabbitPGF2alphareceptor(FP)anditsGirestrictedsignalingpathwayinhibitingwaterabsorptioninrenalcollectingduct。J.Biol。Chem。280(41):35028—37;ZhanP,AlanderC,KanekoH,PilbeamCC,GuanY,ZhangY,BreyerMD,RaiszLG:EffectofdeletionoftheprostaglandinEP4receptoronstimulationofcalciumreleasefromculturedmousecalvariae:Impairedresponsivenessinheterozygous.ProstaglandinsOtherLipidMediat.2005Dec;78(1-4):19—26.;XieL,ChangL,GuanY,WangX:C—reactiveproteinaugmentsinterleukin—8secretioninhumanperipheralbloodmonocytes。JCardiovascPharmacol。2005Nov;46(5):690-6.ZhangY&GuanY:PPAR-gammaagonistsanddiabeticnephropathy。CurrentDiabetesReports2005;5:470-475(InvitedReview)。ParkWC,ZhangY,WuJ,LuW,FanX,DavisL,PozziA,CapdevilaJ,ZengF,BreyerM,GuanY:PPARalphaagonistimprovesdiabeticparametersanddiabeticnephropat(yī)hyindb/dbmice.KidneyInt.2006(inpress)。ZhangY,WuJ,YangG,LuW,HwangM-T,DavisL,BreyerM,GuanY:LiverXreceptor(LXR)agonistTO901317upregulatesSCD1expressioninrenalproximalstraighttubule。AmJPhysiol(RenalPhysiol)(inpress);ParkCW,KimHW,ChungHW,LimSW,YangCW,ChangYS,SugawaraA,GuanY,BreyerMD:AcceleratedDiabeticNephropat(yī)hyinMiceLackingthePeroxisomeProliferator—ActivatedReceptor—.Diabetes(inrevision);NakagawaK,HollaVR,WeiY,WangW-H,WeiS,MeiS,ChaDR,PriceEJr,ZentR,PozziA,BreyerMD,GuanY,FalckJR,WatermanM,CapdevilaJH:SaltsensitivehypertensionisassociatedwithcytochromeP450epoxygenase—mediatedchangesintheactivityoftherenalepithelialsodiumchannel.Nature(inrevision);GuanY,ZhangY,QiZ,YangG,DavisL,WeiMF,F(xiàn)anXF,BreyerR,BreyerMD:ProstaglandinE2receptorEP1isanvasopressorinbloodpressureregulation.CellMetabolism(submitted);ChaDR,SuD.,ZhangY,F(xiàn)anX,BreyerM,GuanY:PeroxisomeProliferatorActivat(yī)edReceptorDeficiencyProtectFromHighFatDiet—InducedInsulinResistanceinAgingMice.Diabetologia(submitted);ChaDR,SuDM,HanJY,ZhangY,F(xiàn)anXF,BreyerMD,GuanY:PPARDualAgonistTesaglitazar(AZ242)attenuatesDiabeticNephropathyindb/dbMice.Diabetes(submitted);ZhangY,LuW,F(xiàn)anXF,ShappellSB,RobertsR,DavisL,GuanY:PPARagonistsdecreasealbuminuriaandslowprogressionofdiabeticnephropathyinobesediabeticdb/dbmice。(inpreparation)。ZhangY,F(xiàn)anXF,CapdevilaJ,BreyerMD,GuanY:Activationofacytochromep450arachidonateepoxygenasecontributestonormalizationofbloodpressureproducedbytheantidiabeticPPARligandtroglitazoneinSHRrats。(inpreparation)。汪南平?教授博士生導(dǎo)師專業(yè):生理學(xué)最后學(xué)歷:醫(yī)學(xué)博士研究專長(zhǎng):心血管分子生物學(xué)與生物工程學(xué)工作單位:北京大學(xué)心血管研究所北京大學(xué)醫(yī)學(xué)部生理學(xué)與病理生理學(xué)系(兼)聯(lián)系地址:北京市海淀區(qū)學(xué)院路38號(hào)北京大學(xué)醫(yī)學(xué)部心血管研究所血管分子生物學(xué)與生物工程學(xué)研究室電話:10-82801146E-mail:npwan.cn學(xué)習(xí)和工作經(jīng)歷1983-1986西安醫(yī)科大學(xué) 醫(yī)學(xué)碩士1986-1988西安醫(yī)科大學(xué)第二臨床學(xué)院?醫(yī)師1989-1990日本北里大學(xué)醫(yī)學(xué)部?訪問學(xué)者1991-1994北京醫(yī)科大學(xué)?醫(yī)學(xué)博士1994-1995德國(guó)柏林自由大學(xué)醫(yī)學(xué)中心 訪問學(xué)者1995—1996美國(guó)印地安那大學(xué)醫(yī)學(xué)院微生物與免疫學(xué)系博士后1996—2000美國(guó)加利福尼亞大學(xué)(河濱)生物醫(yī)學(xué)系博士后2000-2002美國(guó)加利福尼亞大學(xué)(河濱)生物醫(yī)學(xué)系研究助理教授2003-2005美國(guó)加利福尼亞大學(xué)(圣地亞哥)生物工程系研究助理教授北京大學(xué)醫(yī)學(xué)部心血管研究所教授副所長(zhǎng)研究方向代謝性核受體基因轉(zhuǎn)錄調(diào)控與功能基因組學(xué)機(jī)械—生物信號(hào)傳導(dǎo)承擔(dān)課題AmericanHeartAssociat(yī)ionScientistDevelopmentGrant教育部985專項(xiàng)基金國(guó)家自然科學(xué)基金教育部創(chuàng)新團(tuán)隊(duì)基金主要論文Eberle,J。;Garbe,C。;Wang,N.;Orfanos,C.E。Incompleteexpressionofthetyrosinasegenefamily(tyrosinase,TRP—1,andTRP-2)inhumanmalignantmelanomacellsinvitro.PigmentCellRes.1995;8:307—313Farthmann,B.;Eberle,J.;Krasagakis,K.;Gstottner,M.;Wang,N.;Bisson,S.;Orfanos,C。E.RT-PCRfortyrosinase-mRNA-positivecellsinperipheralblood:evaluat(yī)ionstrategyandcorrelationwithknownprognosticmarkersin123melanomapatients。J.InvestDermat(yī)ol。1998;110:263—267Wang,N.,Verna,L。,Hardy,S.,Forsayeth,J。,Zhu,Y。,Ma,K.S.,Stemerman,M。B.Adenovirus-mediatedoverexpressionofc-Junandc—Fosinducesintercellularadhesionmolecule—1andmonocytechemo—at(yī)tractantprotein-1inhumanendothelialcells。ArteriosclerThrombVascBiol.1999;19:2078-2084Zhu,Y.,Liao,H.L。,Wang,N.,F(xiàn)riedli,O.,Verna,L.,Stermerman,M.B.Low—densitylipoproteinactivatesJunN—terminalkinase(JNK)inhumanendothelialcells。BiochimicaetBiophisicaActa1999;1436:557-64Wang,N.,Verna,L。,Hardy,S。,Ma,K。,Zhu,Y。,Birrer,MJ。,Stemerman,M。B.c—Juntriggersapoptosisinhumanvascularendothelialcells.CircRes.1999;85:387-393Liao,H。L.,Zhu,Y。,Wang,N。,Verna,L.,Stemerman,M.B.Selectiveactivationofendothelialcellsbytheantioxidantpyrrolidinedithiocarbamate:involvementofc-JunandJunN-terminalkinaseactivation.Endothelium2000;7:121-133Zhu,Y.,Liao,H.,Wang,N.,Yuan,Y.,Ma,K.,Verna,L。,Stemerman,MB.Lipoproteinpromotescaveolin—1andrastranslocationtocaveolae.Roleofcholesterolinendothelialsignaling。ArteriosclerThrombVascBiol。2000;20:2465-2470Zhu,Y.,Liao,H。,Wang,N.,Ma,K。,Verna,L.,Shyy,J.,Chien,S.,Stemerman,MB.Low—densitylipoprotein-activatedp38ismediatedbyras。
溫馨提示
- 1. 本站所有資源如無特殊說明,都需要本地電腦安裝OFFICE2007和PDF閱讀器。圖紙軟件為CAD,CAXA,PROE,UG,SolidWorks等.壓縮文件請(qǐng)下載最新的WinRAR軟件解壓。
- 2. 本站的文檔不包含任何第三方提供的附件圖紙等,如果需要附件,請(qǐng)聯(lián)系上傳者。文件的所有權(quán)益歸上傳用戶所有。
- 3. 本站RAR壓縮包中若帶圖紙,網(wǎng)頁內(nèi)容里面會(huì)有圖紙預(yù)覽,若沒有圖紙預(yù)覽就沒有圖紙。
- 4. 未經(jīng)權(quán)益所有人同意不得將文件中的內(nèi)容挪作商業(yè)或盈利用途。
- 5. 人人文庫網(wǎng)僅提供信息存儲(chǔ)空間,僅對(duì)用戶上傳內(nèi)容的表現(xiàn)方式做保護(hù)處理,對(duì)用戶上傳分享的文檔內(nèi)容本身不做任何修改或編輯,并不能對(duì)任何下載內(nèi)容負(fù)責(zé)。
- 6. 下載文件中如有侵權(quán)或不適當(dāng)內(nèi)容,請(qǐng)與我們聯(lián)系,我們立即糾正。
- 7. 本站不保證下載資源的準(zhǔn)確性、安全性和完整性, 同時(shí)也不承擔(dān)用戶因使用這些下載資源對(duì)自己和他人造成任何形式的傷害或損失。
最新文檔
- 捐款型的借款合同
- 2024年生日蛋糕定制與航空旅行禮品合作合同3篇
- 2024圈環(huán)線西南環(huán)段A2合同段煤炭資源開發(fā)與供應(yīng)鏈金融支持服務(wù)協(xié)議3篇
- 2025常用承攬加工合同范文
- 地產(chǎn)團(tuán)副總裁聘用合同范本
- 林業(yè)資源安全協(xié)管員招聘合同
- 2024年度商品房轉(zhuǎn)讓合同(含產(chǎn)權(quán)登記費(fèi))3篇
- 2025天津企業(yè)事業(yè)單位的勞動(dòng)合同
- 員工雇傭合同延長(zhǎng)期
- 留學(xué)生服務(wù)合同范例
- 殯葬行業(yè)的風(fēng)險(xiǎn)分析
- 下肢靜脈血栓個(gè)案查房
- 通信工程冬季施工安全培訓(xùn)
- 痛風(fēng)病科普講座課件
- 工作崗位風(fēng)險(xiǎn)評(píng)估報(bào)告
- 護(hù)理查房肺部感染心衰
- 拒執(zhí)罪申請(qǐng)書范本
- 《阿米巴經(jīng)營(yíng)》讀書分享
- 鉛酸鋰電池回收項(xiàng)目計(jì)劃書
- 北京市朝陽區(qū)2023-2024學(xué)年七年級(jí)上學(xué)期期末檢測(cè)語文試卷+
- (常州專版)江蘇省常州市2023-2024學(xué)年六年級(jí)數(shù)學(xué)上冊(cè)期末學(xué)情調(diào)研檢測(cè)卷一(蘇教版)
評(píng)論
0/150
提交評(píng)論